Beam Therapeutics Inc.
$29.32
-1.16 (-3.81%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +10.7%
- 3 Months
- -11.0%
- YTD
- +5.8%
- 1 Year
- +73.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 76.7%
- Largest decline max drawdown, since Aug 2025
- -38.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.09
Own BEAM?
See how BEAM contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.